Dexamethasone Sodium Phosphate
36 NDCs across 11 manufacturers|36 Generic,0 Brand
Dexamethasone Sodium Phosphate is used to treat addison disease, brain edema, bursitis, ulcerative colitis, collagen diseases and dermatitis herpetiformis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jan 1, 1982. In 2024, Medicare Part D spent $3 million on Dexamethasone Sodium Phosphate across 96,000 claims for 58,000 beneficiaries.
Dexamethasone Sodium Phosphate is available as 36 NDCs from 11 manufacturers (36 generic, 0 brand), with NADAC prices from $0.18 to $8.17 per ML — the most expensive product costs about 45× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Active FDA drug shortage
19 Dexamethasone Sodium Phosphate presentations are currently listed in FDA's drug shortage database (first posted Feb 8, 2019). Shortages can move NADAC prices in the following weeks.
Total NDCs
36
36G / 0B
Manufacturers
11
competing in market
Price Spread
$0.18 – $8.17
per ML
7d Activity
avg -2.6% WoW · of 36 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Fresenius Kabi USA, LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Corticosteroid class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
11 manufacturers producing DEXAMETHASONE SODIUM PHOSPHATE(2 pricing outliers)
Frequently Asked Questions
What is Dexamethasone Sodium Phosphate used to treat?
Dexamethasone Sodium Phosphate is used to treat addison disease, brain edema, bursitis, ulcerative colitis, collagen diseases and dermatitis herpetiformis, per the National Library of Medicine's MED-RT classification.
When did Dexamethasone Sodium Phosphate become available as a generic?
FDA approved the first generic Dexamethasone Sodium Phosphate (ANDA) on Jan 1, 1982.
How much does Medicare spend on Dexamethasone Sodium Phosphate?
In 2024, Medicare Part D spent $3 million on Dexamethasone Sodium Phosphate across 96,000 claims for 58,000 beneficiaries.
Is Dexamethasone Sodium Phosphate in shortage?
Yes — FDA's drug shortage database currently lists 19 Dexamethasone Sodium Phosphate presentations with status "Current", first posted Feb 8, 2019.
How many Dexamethasone Sodium Phosphate products are on the market?
The Dexamethasone Sodium Phosphate drug market contains 36 NDCs from 11 manufacturers — 36 generic and 0 brand products.
What is the price range for Dexamethasone Sodium Phosphate?
NADAC reference prices for Dexamethasone Sodium Phosphate range from $0.1807 to $8.1745 per ML — the most expensive product costs about 45× the cheapest.
Which manufacturers make Dexamethasone Sodium Phosphate?
11 manufacturers list Dexamethasone Sodium Phosphate in NADAC. Ranked by number of NDCs, the largest are Fresenius Kabi USA, LLC (8), Mylan Institutional LLC (8), Eugia US LLC (5), Hikma Pharmaceuticals USA Inc. (4), Sagent Pharmaceuticals (3).
How has the price of Dexamethasone Sodium Phosphate changed recently?
Over the past 7 days, 12 Dexamethasone Sodium Phosphate NDCs rose and 10 fell, with a market-wide average change of -2.6%.